Navigation Links
PTC Therapeutics Appoints Robert Spiegel, M.D. as Chief Medical Officer
Date:3/30/2011

Jay Barth will lead all clinical development programs for ataluren, an investigational new drug for the treatment of nonsense mutation genetic disorders.  Ataluren is currently being investigated for use in Duchenne and Becker muscular dystrophy, cystic fibrosis, hemophilia and methylmalonic acidemia due to a nonsense mutation.  Dr. Barth received his undergraduate degree from Columbia University and his medical degree from the University of Pennsylvania School of Medicine.  He completed a residency in Pediatrics at the Columbia-Presbyterian Medical Center and a fellowship in Pediatric Gastroenterology, Liver disease and Nutrition at the New England Medical Center.  In his previous role at Merck, Dr. Barth served as Executive Director of Clinical Development and was responsible for global clinical development programs in respiratory, supportive oncology and gastroenterology.  

"We are excited to welcome Dr. Spiegel as a member of our senior management team.  Bob's extensive clinical development experience, especially his track record in leading discussions with regulatory authorities, will be invaluable as we move ataluren toward regulatory filings," stated Dr. Stuart Peltz, President and CEO of PTC Therapeutics.  "Jay has been a key contributor to the successful execution of our ataluren development plan since 2009 and the expansion of his role further supports advancement of our development efforts with ataluren."

About PTC Therapeutics, Inc.  

PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes.  Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function.  PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders,
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
(Date:3/27/2015)... 27, 2015 According to a ... Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), ... (AF, VT, WPW) - Global Forecasts to 2019 ", published ... reach around ~$4.73 Billion by 2019 with a CAGR ... 2019. Browse   90   ma ...
(Date:3/27/2015)... MARLBOROUGH, Mass. , March 27, 2015 ... ) and privately-held MirImmune LLC, today announced ... license agreement to RXi,s novel and proprietary ... cell-based cancer immunotherapies. The collaboration has the ... and patient friendly cancer treatments that could ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... , NEW YORK, Dec. 2 ... available in its catalogue: , Electrodes for Medical ... http://www.reportlinker.com/p0164320/Electrodes-for-Medical-Devices---A-Global-Market-Perspective.html , Electrodes in electronic devices detect electrical ... created by chemical reactions. Medical application areas include blood ...
... , PALO ALTO, Calif., Dec. 2 ... 2009, Varian, Inc. filed with the U.S. Securities and Exchange Commission ... October 2, 2009. This Annual Report may be accessed through ... "SEC Filings," and then on "10-K" in the table shown. ...
Cached Medicine Technology:Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 2Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 3Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 4Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 5Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 6Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 7
(Date:3/27/2015)... According to Health Day , on ... Abstinence Syndrome (NAS) are causing alarm for Florida officials. ... process for a month of their lives- and can ... vomiting. The condition is precipitated by drug use during ... (and employing medically assisted drug treatment) will also inflict ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global ... the SM1120 MEMS based ultra-miniature pressure sensor designed especially ... at only 220um x 75um provides ample space for ... With industry leading in vivo drift performance of ... broad operating pressure range from 0 to 1,100 mmHg ...
(Date:3/27/2015)... OR (PRWEB) March 27, 2015 California’s ... winter blizzards in Boston and the United States Northeast, ... patterns. Earth warming global atmosphere is creating changes in ... PhD, historical climatologist and former NASA researcher, speaking on ... The result is not only a warmer and dryer ...
(Date:3/27/2015)... 2015 Operatic contenders and their avid ... April 17th. The universally acclaimed baritone Sherrill Milnes will ... Opera Idol at The Merion in Evanston. The event ... drawn aspiring opera singers from around the country. “This ... the finest young talent in the country,” said Margaret ...
(Date:3/27/2015)... To address their number one lawn care question ... filming this video to explain the complicated dynamics between the ... often expected to thrive in, be it in dense building ... survive. Anytime a sun-loving plant is put in the shade ... homeowners try to amend this issue by applying large quantities ...
Breaking Medicine News(10 mins):Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:Opera Idol Competition At The Merion In Evanston 2Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
... treatment could prevent several bone problems, , TUESDAY, Oct. 27 ... treatment with large doses of vitamin D2 can eliminate vitamin ... bay for up to six years. , The dosage ... was large but did not appear to be toxic, according ...
... ... vast reach across the U.S. healthcare industry with Susan G. Komen,s mission to cure ... ... with Susan G. Komen for the Cure®, the world,s largest breast cancer advocacy organization. ...
... Robert A. Douglas, 1st Vice President Senior Consultant Sales, ... Career Division national sales growth, Expansion of new RJR sales ... management experience and over 6 years of sales training experience ... in the development and implementation of several new divisions to ...
... Vestara, ... has been awarded a MedAssets supplier contract. MedAssets serves more than 1,700 hospitals and ... ... provider of the industry,s only automated pharmaceutical waste management solution, announced today that it ...
... , ... Homonculus Press, Mexico City, announces the publication of The American ... revealed two sets of parties of interest: A complaint against the first ... 24 Feb 2006 at the Lumpini Police Station against Bumrungrad International Hospital ...
... ... ... -- Morehead, the human capital research firm, will host a webinar titled "A Two-Pronged Strategy ... 17, 2009 at 1:00 p.m. EST. , , ,In this webinar, David Rowlee, Ph.D., ...
Cached Medicine News:Health News:Short-Term, High-Dose Vitamin D2 May Ease Deficiency 2Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 2Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 3Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 4Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 2Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 3Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 4Health News:Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management Solution 2Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 2Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 3Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 4Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 5Health News:Morehead Presents Webinar on 'A Two-Pronged Strategy to Reduce Nurse Turnover' 2
... Optima MAX has the highest g-force ever. ... more than force. Optima MAX combines maximum ... achieve benchtop performance that's worlds apart from ... superior design, and enhanced efficiency, Optima takes ...
... generating 694,000 x g at ... Beckman Coulter's Optima L-90K Ultracentrifuge ... separations in less time. This ... a broad range of superb ...
... chemistry system brings versatility in a ... laboratory. A model of innovation and ... system features state-of-the-art Dimension technology, specifically ... in a flexible, affordable, easy-to-use system ...
... Dimension clinical chemistry integrated systems combine the ... cartridge, the power of the Multiply and ... the heterogeneous module to meet the challenges ... broad test menus, the systems can meet ...
Medicine Products: